c-Met activation in medulloblastoma induces tissue factor expression and activity: Effects on cell migration

Carcinogenesis

Volumn 30, Issue 7, 2009, Pages 1089-1096

  Provençal, Mathieu ^a   Labbé, David ^a   Veitch, Ryan ^b   Boivin, Dominique ^a   Rivard, Georges Étienne ^b   Sartelet, Hervé ^b   Robitaille, Yves ^b   Gingras, Denis ^a   Béliveau, Richard ^a,b  

^a UNIVERSITÉ DU QUÉBEC À MONTRÉAL   (Canada)

^b UNIVERSITY OF MONTREAL   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

ACTIN; BLOOD CLOTTING FACTOR 7A; FIBRIN; PROTEIN TYROSINE KINASE; SCATTER FACTOR; SCATTER FACTOR RECEPTOR; THROMBOPLASTIN;

APOPTOSIS; ARTICLE; CANCER CELL; CANCER CELL CULTURE; CANCER TISSUE; CELL MIGRATION; CELL PROLIFERATION; CELL STIMULATION; CHILDHOOD CANCER; CONTROLLED STUDY; ENZYME ACTIVATION; ENZYME ACTIVITY; GENE ACTIVATION; GENE EXPRESSION; GENE TRANSLOCATION; HUMAN; HUMAN CELL; HUMAN TISSUE; MEDULLOBLASTOMA; PRIORITY JOURNAL; TUMOR VASCULARIZATION;

BRAIN NEOPLASMS; CELL LINE, TUMOR; CELL MOVEMENT; FACTOR VII; HEPATOCYTE GROWTH FACTOR; HUMANS; MEDULLOBLASTOMA; PROTO-ONCOGENE PROTEINS C-MET; THROMBOPLASTIN;

EID: 67650162494     PISSN: 01433334     EISSN: 14602180     Source Type: Journal    
DOI: 10.1093/carcin/bgp085     Document Type: Article

References (48)

1. Wechsler-Reya,R. et al. (2001) The developmental biology of brain tumors. Annu. Rev. Neurosci., 24, 385-428.
2. Rossi,A. et al. (2008) Medulloblastoma: From molecular pathology to therapy. Clin. Cancer Res., 14, 971-976.
3. Gilbertson,R.J. (2004) Medulloblastoma: Signalling a change in treatment. Lancet Oncol., 5, 209-218.
4. Ellison,D. (2002) Classifying the medulloblastoma: Insights from morphology and molecular genetics. Neuropathol. Appl. Neurobiol., 28, 257-282.
5. Gilbertson,R.J. et al. (2008) The origins of medulloblastoma subtypes. Annu. Rev. Pathol., 3, 341-365.
6. Polkinghorn,W.R. et al. (2007) Medulloblastoma: Tumorigenesis, current clinical paradigm, and efforts to improve risk stratification. Nat. Clin. Pract. Oncol., 4, 295-304.
7. Zwick,E. et al. (2002) Receptor tyrosine kinases as targets for anticancer drugs. Trends Mol. Med., 8, 17-23.
8. Goumnerova,L.C. (1996) Growth factor receptors and medulloblastoma. J. Neurooncol., 29, 85-89.
9. Grotzer,M.A. et al. (2000) Neurotrophin receptor TrkC predicts good clinical outcome in medulloblastoma and other primitive neuroectodermal brain tumors. Klin. Padiatr., 212, 196-199.
10. Duplan,S.M. et al. (2002) Antitumor activity of fibroblast growth factors (FGFs) for medulloblastoma may correlate with FGF receptor expression and tumor variant. Clin. Cancer Res., 8, 246-257.
11. Gilbertson,R.J. et al. (1998) Expression of the ErbB-neuregulin signaling network during human cerebellar development: Implications for the biology of medulloblastoma. Cancer Res., 58, 3932-3941.
12. MacDonald,T.J. et al. (2001) Expression profiling of medulloblastoma: PDGFRA and the RAS/MAPK pathway as therapeutic targets for metastatic disease. Nat. Genet., 29, 143-152.
13. Gilbertson,R.J. et al. (2003) PDGFRB is overexpressed in metastatic medulloblastoma. Nat. Genet., 35, 197-198.
14. Hartmann,W. et al. (2005) Insulin-like growth factor II is involved in the proliferation control of medulloblastoma and its cerebellar precursor cells. Am. J. Pathol., 166, 1153-1162.
15. Birchmeier,C. et al. (2003) Met, metastasis, motility and more. Nat. Rev. Mol. Cell Biol., 4, 915-925.
16. Li,Y. et al. (2005) The scatter factor/hepatocyte growth factor: c-met pathway in human embryonal central nervous system tumor malignancy. Cancer Res., 65, 9355-9362.
17. Li,Y. et al. (2008) Functional and molecular interactions between the HGF/c-Met pathway and c-Myc in large-cell medulloblastoma. Lab. Invest., 88, 98-111.
18. Benvenuti,S. et al. (2007) The MET receptor tyrosine kinase in invasion and metastasis. J. Cell. Physiol., 213, 316-325.
19. Wang,X. et al. (2003) Potent and selective inhibitors of the Met [hepatocyte growth factor/scatter factor (HGF/SF) receptor] tyrosine kinase block HGF/SF-induced tumor cell growth and invasion. Mol. Cancer Ther., 2, 1085-1092.
20. Abounader,R. et al. (2005) Scatter factor/hepatocyte growth factor in brain tumor growth and angiogenesis. Neuro Oncol., 7, 436-451.
21. Hamasuna,R. et al. (1999) Regulation of matrix metalloproteinase-2 (MMP-2) by hepatocyte growth factor/scatter factor (HGF/SF) in human glioma cells: HGF/SF enhances MMP-2 expression and activation accompanying up-regulation of membrane type-1 MMP. Int. J. Cancer, 82, 274-281.
22. Wang,H. et al. (2000) Hepatocyte growth factor enhances MMP activity in human endothelial cells. Biochem. Biophys. Res. Commun. 272, 900-905.
23. Moriyama,T. et al. (1998) Up-regulation of vascular endothelial growth factor induced by hepatocyte growth factor/scatter factor stimulation in human glioma cells. Biochem. Biophys. Res. Commun., 249, 73-77.
24. Boccaccio,C. et al. (2005) The MET oncogene drives a genetic programme linking cancer to haemostasis. Nature, 434, 396-400.
25. Boccaccio,C. et al. (2005) A functional role for hemostasis in early cancer development. Cancer Res., 65, 8579-8582.
26. Wojtukiewicz,M.Z. et al. (2001) The hemostatic system and angiogenesis in malignancy. Neoplasia, 3, 371-384.
27. Nijziel,M.R. et al. (2006) From Trousseau to angiogenesis: The link between the haemostatic system and cancer. Neth. J. Med., 64, 403-410.
28. Varki,A. (2007) Trousseau's syndrome: Multiple definitions and multiple mechanisms. Blood, 110, 1723-1729.
29. Price,G.C. et al. (2004) Tissue factor and tissue factor pathway inhibitor. Anaesthesia, 59, 483-492.
30. Ott,I. et al. (2005) Tissue factor cytoplasmic domain stimulates migration by activation of the GTPase Rac1 and the mitogen-activated protein kinase p38. Circulation, 111, 349-355.
31. Bromberg,M.E. et al. (1999) Role of tissue factor in metastasis: functions of the cytoplasmic and extracellular domains of the molecule. Thromb. Haemost., 82, 88-92.
32. Versteeg,H.H. (2004) Tissue factor as an evolutionary conserved cytokine receptor: Implications for inflammation and signal transduction. Semin. Hematol., 41, 168-172.
33. Belting,M. et al. (2004) Regulation of angiogenesis by tissue factor cytoplasmic domain signaling. Nat. Med., 10, 502-509.
34. Dietzen,D.J. et al. (2004) Lipid rafts are necessary for tonic inhibition of cellular tissue factor procoagulant activity. Blood, 103, 3038-3044.
35. Holen,T. et al. (2002) Positional effects of short interfering RNAs targeting the human coagulation trigger Tissue Factor. Nucleic Acids Res., 30, 1757-1766.
36. Provencal,M. et al. (2008) Tissue factor pathway inhibitor (TFPI) interferes with endothelial cell migration by inhibition of both the Erk pathway and focal adhesion proteins. Thromb. Haemost., 99, 576-585.
37. Fan,X. et al. (2003) hTERT gene amplification and increased mRNA expression in central nervous system embryonal tumors. Am. J. Pathol. 162, 1763-1769.
38. Guan,M. et al. (2002) Quantitative reverse transcription-PCR measurement of tissue factor mRNA in glioma. Mol. Biotechnol., 20, 123-129.
39. Bolanos-Garcia,V.M. (2005) MET meet adaptors: Functional and structural implications in downstream signalling mediated by the Met receptor. Mol. Cell. Biochem., 276, 149-157.
40. Rong,Y. et al. (2005) PTEN and hypoxia regulate tissue factor expression and plasma coagulation by glioblastoma. Cancer Res., 65, 1406-1413.
41. Rong,Y. et al. (2006) Early growth response gene-1 regulates hypoxia-induced expression of tissue factor in glioblastoma multiforme through hypoxia-inducible factor-1-independent mechanisms. Cancer Res., 66, 7067-7074.
42. Takano,S. et al. (2000) Tissue factor, osteopontin, alphavbeta3 integrin expression in microvasculature of gliomas associated with vascular endothelial growth factor expression. Br. J. Cancer, 82, 1967-1973.
43. Singh,V.P. et al. (2008) Src-mediated cortactin phosphorylation regulates actin localization and injurious blebbing in acinar cells. Mol. Biol. Cell, 19, 2339-2347.
44. Herynk,M.H. et al. (2007) Activation of Src by c-Met overexpression mediates metastatic properties of colorectal carcinoma cells. J. Exp. Ther. Oncol., 6, 205-217.
45. Bardos,H. et al. (1996) Fibrin deposition in primary and metastatic human brain tumours. Blood Coagul. Fibrinolysis, 7 536-548.
46. Boccaccio,C. et al. (2006) Cancer and blood coagulation. Cell. Mol. Life Sci., 63, 1024-1027.
47. Ornstein,D.L. et al. (2002) The coagulation system as a target for the treatment of human gliomas. Semin. Thromb. Hemost., 28, 19-28.
48. Shoji,M. et al. (2008) Targeting tissue factor-expressing tumor angiogenesis and tumors with EF24 conjugated to factor VIIa. J. Drug Target., 16, 185-197.